Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium for Remifentanil-induced Hyperalgesia
NCT01025245Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Nov 2009
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of magnesium sulfate in hyperalgesia (3 arms), sponsored by Yonsei University. Primary endpoint: Tactile pain thresholds adjacent to the surgical wound at 48 hours. Started Nov 2009; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
hyperalgesia
Beyond the preview
Go deeper on NCT01025245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01025245.